Crossref
CIRCULATING LEVELS OF GALECTIN-9 ARE A POTENTIAL BIOMARKER OF SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG CANCER
Brazilian Journal of Oncology · 15.12.2023 · 19 (CP)
DOI: 10.1055/s-0046-1824930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brazilian Journal of Oncology, erschienen am 15.12.2023. Verfasst von Guilherme Vieira de Mendonça Filho und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Filho, G. V. D. M., Costa, G. J., Martins, M. R., & Torres, L. C. (2023). CIRCULATING LEVELS OF GALECTIN-9 ARE A POTENTIAL BIOMARKER OF SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG CANCER. Brazilian Journal of Oncology, 19(CP). https://doi.org/10.1055/s-0046-1824930
Vancouver
Filho GVDM, Costa GJ, Martins MR, Torres LC. CIRCULATING LEVELS OF GALECTIN-9 ARE A POTENTIAL BIOMARKER OF SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG CANCER. Brazilian Journal of Oncology. 2023;19(CP). doi:10.1055/s-0046-1824930
BibTeX
@article{Filho2023,
author = {Filho, Guilherme Vieira de Mendonça and Costa, Guilherme Jorge and Martins, Mario Rino and Torres, Leuridan Cavalcante},
title = {CIRCULATING LEVELS OF GALECTIN-9 ARE A POTENTIAL BIOMARKER OF SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG CANCER},
journal = {Brazilian Journal of Oncology},
year = {2023},
volume = {19},
number = {CP},
doi = {10.1055/s-0046-1824930}
}
EUVIMED